Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease

Fabrizio Tomai1, Flavio Ribichini, Anna S Ghini

  • 1Division of Cardiology and Cardiac Surgery, Università di Roma Tor Vergata, European Hospital, via Portuense 700, 00149 Rome, Italy. f.tomai@tiscali.it

Insights

Elevated C-reactive protein levels, a marker of inflammation, are linked to impaired coronary microvascular function in coronary artery disease (CAD) patients. This dysfunction affects both endothelium-dependent and independent blood flow responses.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Inflammation Research

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • Coronary microcirculatory dysfunction (CMD) plays a significant role in the pathophysiology of CAD.
  • The precise role of systemic inflammation, indicated by C-reactive protein (CRP), in CMD remains unclear.

Purpose of the Study:

  • To investigate the association between elevated C-reactive protein (CRP) levels and coronary microcirculatory function in patients with CAD.
  • To evaluate the impact of CRP on endothelium-dependent and endothelium-independent coronary blood flow (CBF) responses.

Main Methods:

  • A study involving 28 patients with single-vessel CAD.
  • Patients were categorized into normal (<5 mg/L) and elevated (>5 mg/L) CRP groups.
  • Coronary blood flow (CBF) was measured using intracoronary Doppler and quantitative coronary angiography during substance P and adenosine infusions.

Main Results:

  • Patients with elevated CRP exhibited significantly reduced increases in CBF in response to both substance P and adenosine compared to those with normal CRP.
  • Multivariable analysis identified elevated CRP as an independent predictor of impaired endothelium-dependent and endothelium-independent CBF responses.
  • These findings suggest a direct link between systemic inflammation and microvascular dysfunction in CAD.

Conclusions:

  • Systemic inflammation, evidenced by elevated CRP, is independently associated with coronary microvascular dysfunction in CAD patients.
  • This dysfunction may contribute to myocardial ischemia, particularly in unstable patients.
  • Targeting inflammation could be a potential therapeutic strategy for improving microvascular function in CAD.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...